As the COVID-19 pandemic hit, emergency rooms and doctor’s offices were left empty. The number of Telehealth visits began to soar and amid changes in regulation and perception by patients, telehealth was now seen as a viable and thriving option.
In part one of this three-part series, Peter Urbanowicz and Karen Davis from A&M's Healthcare Industry Group are joined by Dr. David Shulkin, former Secretary of the United States Department of Veterans Affairs and Senior Advisor of A&M's Healthcare Industry Group and Dr. Lewis Levy, Chief Medical Officer of Teladoc. In this podcast they'll discuss the dramatic increase in telehealth usage since the COVID-19 crisis began, the strategies that providers and other organizations have been imploring and implementing, and what the future of telehealth looks like in a constantly changing healthcare environment.
Please contact Peter or Karen if you would like to have a conversation.
Peter Urbanowicz
Managing Director and Co-Head of Healthcare Industry Group
purbanowicz@alvarezandmarsal.com
+1 214 662 7389
Karen Davis
Managing Director, Healthcare Industry Group
kdavis@alvarezandmarsal.com
+1 205 223 6823
For other podcasts in this series:
Part II – Addressing Necessary Regulatory and Compliance Risk
Part III - The Future of Telehealth
Contract Research Organisations M&A Market
March 28, 2025
Rising cost pressures, stricter regulatory demands and advancements in emerging therapeutics are intensifying competition within the industry. These dynamics are fuelling the demand for greater efficiency in development lifecycles, creating significant opportunities for outsourced providers like Contract Research Organisations (CROs).
Healthcare Workforce Predictions for 2025
March 19, 2025
The healthcare landscape in 2025 is marked by a complex interplay of financial pressures, persistent workforce shortages, and rapid technological advancements. While healthcare providers have stabilized post-pandemic, they face shrinking revenues coupled with escalating workforce expense, which now comprise a significant portion of total expenses.
Mass General Brigham is Redefining ROI Through the Lens of its Mission to Improve Human Health
March 18, 2025
How do you fundamentally redefine “ROI”? Niyum Gandhi, CFO of Mass General Brigham, the largest employer in New England and the largest medical research organization in the world, shares about his Moonshot to do just that.
The Clock is Ticking: Why Health Plans Must Act Now to Maximize Star Ratings Before the 2026 HEI Update
March 12, 2025
The October 2026 Star Ratings release presents both an opportunity and a challenge for health plans as they navigate uncertain Health Equity Index (HEI) changes. With evolving CMS equity-focused metrics, shifting data collection requirements, and potential weighting adjustments, health plans must take immediate action to optimize their Star Ratings before potential regulatory shifts in 2027.
